Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32

MediWound Ltd.

MediWound Ltd.

MDWD

0.00

Oppenheimer analyst Francois Brisebois maintains MediWound (NASDAQ: MDWD) with a Outperform and lowers the price target from $33 to $32.